TCL Archive In Brief: Ortho Biotec gives $1 Million To Fund Fatigue Initiative; Lippman, Pike Honored November 18, 1994
TCL Archive Five-Year Course of Tamoxifen Remains Standard Treatment In HR+ Breast Cancer July 26, 2002
TCL Archive In Brief: NCAB Will Consider Holding “Circuit Rider” Meetings; Kaplan Asked to Speak On Hybridomas May 1, 1981